IS5485A - Carbohydrate derivatives - Google Patents

Carbohydrate derivatives

Info

Publication number
IS5485A
IS5485A IS5485A IS5485A IS5485A IS 5485 A IS5485 A IS 5485A IS 5485 A IS5485 A IS 5485A IS 5485 A IS5485 A IS 5485A IS 5485 A IS5485 A IS 5485A
Authority
IS
Iceland
Prior art keywords
carbohydrate derivatives
carbohydrate
derivatives
Prior art date
Application number
IS5485A
Other languages
Icelandic (is)
Other versions
IS2527B (en
Inventor
Adriaan Anton Van Boeckel Constant
Petitou Maurice
Duchaussoy Philippe
Maria Dreef-Tromp Cornelia
Egbertus Maria Basten Johannes
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of IS5485A publication Critical patent/IS5485A/en
Publication of IS2527B publication Critical patent/IS2527B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
IS5485A 1997-11-19 2000-05-09 hydrocarbon Derivatives IS2527B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203613 1997-11-19
PCT/EP1998/007518 WO1999025720A1 (en) 1997-11-19 1998-11-16 Carbohydrate derivatives

Publications (2)

Publication Number Publication Date
IS5485A true IS5485A (en) 2000-05-09
IS2527B IS2527B (en) 2009-07-15

Family

ID=8228942

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5485A IS2527B (en) 1997-11-19 2000-05-09 hydrocarbon Derivatives

Country Status (34)

Country Link
US (1) US6174863B1 (en)
EP (1) EP1032579B1 (en)
JP (1) JP4364959B2 (en)
KR (1) KR100518497B1 (en)
CN (1) CN1177855C (en)
AR (1) AR017640A1 (en)
AT (1) ATE239030T1 (en)
AU (1) AU746959B2 (en)
BR (1) BRPI9804699B1 (en)
CA (1) CA2253113C (en)
CO (1) CO4990974A1 (en)
CZ (1) CZ293639B6 (en)
DE (1) DE69814140T2 (en)
DK (1) DK1032579T3 (en)
EE (1) EE04348B1 (en)
ES (1) ES2198081T3 (en)
HK (1) HK1028406A1 (en)
HU (1) HU226685B1 (en)
ID (1) ID21287A (en)
IL (1) IL126893A (en)
IS (1) IS2527B (en)
NO (1) NO310723B1 (en)
NZ (1) NZ332834A (en)
PE (1) PE134799A1 (en)
PL (1) PL188229B1 (en)
PT (1) PT1032579E (en)
RU (1) RU2210573C2 (en)
SG (1) SG72889A1 (en)
SK (1) SK284134B6 (en)
TR (1) TR199802372A2 (en)
TW (1) TW448180B (en)
UA (1) UA49089C2 (en)
WO (1) WO1999025720A1 (en)
ZA (1) ZA9810559B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI289566B (en) * 1999-12-07 2007-11-11 N.V.Organon Antithrombotic compound
AU2002243630A1 (en) 2001-01-23 2002-08-06 Massachusetts Institute Of Technology Solid- and solution -phase synthesis of heparin and other glycosaminoglycans
DK1569912T3 (en) 2002-12-03 2015-06-29 Pharmacyclics Inc 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors.
CN1317287C (en) * 2003-04-18 2007-05-23 山东大学 Oligose polysulfate and preparation process thereof
CN103788141B (en) * 2004-03-04 2016-08-17 普罗吉恩制药有限公司 Sulfated oligosaccharide derivatives
CN102046781A (en) 2008-05-30 2011-05-04 动量制药公司 Saccharide structures and methods of making and using such structures
US20110150976A1 (en) * 2008-09-10 2011-06-23 Transpharma Medical Ltd. Transdermal delivery of oligosaccharides
ES2939741T3 (en) * 2009-07-31 2023-04-26 Reliable Biopharmaceutical Llc Process for preparing fondaparinux sodium and useful intermediates in the synthesis thereof
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
CA2839139A1 (en) * 2011-06-17 2012-12-20 Carbomimetics Synthetic pentasaccharides having short half-life and high activity
EP2578594A1 (en) 2011-10-04 2013-04-10 Sanofi Process of preparation of L-iduronic acid comprising a decarboxylation/intramolecular cyclisation tandem reaction
US9873712B2 (en) * 2014-10-03 2018-01-23 Amphastar Pharmaceuticals, Inc. Method of purifying idraparinux sodium
CN109134555B (en) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 Anticoagulant pentasaccharide compound and preparation method and medical application thereof
CN109134554B (en) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 Anticoagulant pentasaccharide compound and preparation method and medical application thereof
CN109134553B (en) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 Anticoagulant pentasaccharide compound and preparation method and medical application thereof
WO2021043631A1 (en) 2019-09-02 2021-03-11 Hepoligo Solutions Aps Intermediates useful for preparing iduronic acid containing di- and polysaccharides
WO2021211441A1 (en) * 2020-04-13 2021-10-21 The Board Of Regents Of The University Of Oklahoma Modified sugar polymers with low anticoagulant activity and therapeutic activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300099A1 (en) * 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
DE69100275T2 (en) * 1990-04-23 1993-12-02 Akzo Nv Carbohydrate derivatives containing a trisaccharide unit.
IL102758A (en) * 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
NO310723B1 (en) 2001-08-20
NO985365D0 (en) 1998-11-18
ES2198081T3 (en) 2004-01-16
SK7362000A3 (en) 2000-10-09
NO985365L (en) 1999-05-20
KR100518497B1 (en) 2005-12-16
KR19990045312A (en) 1999-06-25
BR9804699A (en) 2000-12-26
AU9324298A (en) 1999-06-17
SK284134B6 (en) 2004-09-08
CZ293639B6 (en) 2004-06-16
ATE239030T1 (en) 2003-05-15
ID21287A (en) 1999-05-20
BRPI9804699B1 (en) 2016-07-12
EE04348B1 (en) 2004-08-16
EP1032579B1 (en) 2003-05-02
EE200000301A (en) 2001-12-17
HUP9802663A2 (en) 1999-06-28
RU2210573C2 (en) 2003-08-20
IL126893A0 (en) 1999-09-22
ZA9810559B (en) 1999-05-15
CO4990974A1 (en) 2000-12-26
HK1028406A1 (en) 2001-02-16
AU746959B2 (en) 2002-05-09
PT1032579E (en) 2003-08-29
TR199802372A2 (en) 1999-06-21
PE134799A1 (en) 2000-01-07
PL188229B1 (en) 2004-12-31
HU226685B1 (en) 2009-06-29
DE69814140D1 (en) 2003-06-05
EP1032579A1 (en) 2000-09-06
DE69814140T2 (en) 2004-04-08
CA2253113C (en) 2008-06-17
NZ332834A (en) 2000-01-28
HUP9802663A3 (en) 2000-04-28
WO1999025720A1 (en) 1999-05-27
DK1032579T3 (en) 2003-08-25
IS2527B (en) 2009-07-15
IL126893A (en) 2003-05-29
AR017640A1 (en) 2001-09-12
CA2253113A1 (en) 1999-05-19
PL329789A1 (en) 1999-05-24
US6174863B1 (en) 2001-01-16
CN1177855C (en) 2004-12-01
TW448180B (en) 2001-08-01
CZ376198A3 (en) 1999-06-16
CN1222524A (en) 1999-07-14
UA49089C2 (en) 2002-09-16
SG72889A1 (en) 2000-05-23
HU9802663D0 (en) 1999-01-28
JP4364959B2 (en) 2009-11-18
JPH11217394A (en) 1999-08-10

Similar Documents

Publication Publication Date Title
DK1005446T3 (en) N-aroylphenylalanine derivatives
ATE235220T1 (en) RESOCINE DERIVATIVES
ID22781A (en) Nicotynamide derivatives
DE69817186D1 (en) DIAMINORHODAMIN DERIVATIVES
ATE393145T1 (en) PYRIDINE DERIVATIVES
ATE310742T1 (en) C-4ß-SUBSTITUTED MACROLIDE DERIVATIVES
PT915088E (en) D-PROLINA DERIVATIVES
NO20000231D0 (en) Dolastatin-15 derivatives
ATE255098T1 (en) SUBSTITUTED CHROMEDER DERIVATIVES
PT1003719E (en) N-SULFONYL-GLYCINALQUINYLXXYLENEEMETHYLAMIDE MICROBICIDARY DERIVATIVES
PT1027362E (en) 2-HALOGEN-6-O-SUBSTITUTED CETOLID DERIVATIVES
ATE239030T1 (en) CARBOHYDRATE DERIVATIVES
DE69841086D1 (en) 5-deoxy-cytidine derivatives
ATE255099T1 (en) SUBSTITUTED CHROMEDER DERIVATIVES
ATE231508T1 (en) AZYCLIC NUCLEOSIDE DERIVATIVES
DK0818459T3 (en) Carbohydrate derivatives
DE69829682D1 (en) CIS-DISUBSTITUTED AMINOCYCLOALKYL-PYRROLIDINE DERIVATIVES
DE69828780D1 (en) AMIDINOCAMPTPTHECIN DERIVATIVES
NO981495D0 (en) Phenoxymetylpiperidin derivatives
DK0966437T3 (en) 5-Aroylnaphthalene derivatives
DK1015447T3 (en) Piperidinylmethyloxazolidinone derivatives
BR9605988A (en) Carbohydrate derivatives
NO993562L (en) Gemcitabine derivatives
DE69825852D1 (en) Riboflavin glucoside
ATA69896A (en) 3-METHYLIMINO-3-CEPHEM DERIVATIVES 3-METHYLIMINO-3-CEPHEM DERIVATIVES